PI
DGX icon

PFG Investments’s Quest Diagnostics DGX Stock Holding History

PFG Investments’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$390K Buy
1,842
+19
+1% +$3.73K 0.02% 803
2026
Q1 		$357K Sell
1,823
-50
-3% -$9.71K 0.02% 764
2025
Q4 		$325K Buy
1,873
+6
+0.3% +$1.09K 0.02% 769
2025
Q3 		$356K Sell
1,867
-85
-4% -$15.1K 0.02% 689
2025
Q2 		$351K Buy
1,952
+92
+5% +$16K 0.02% 668
2025
Q1 		$315K Buy
1,860
+20
+1% +$3.29K 0.02% 683
2024
Q4 		$278K Buy
1,840
+40
+2% +$6.22K 0.02% 747
2024
Q3 		$279K Buy
+1,800
New +$269K 0.02% 741

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

PFG Investments's DGX Position: Q2 2026 in Review

PFG Investments increased its Quest Diagnostics (DGX) stake by 1% in Q2 2026, buying an estimated $3.73K and bringing the position to 1,842 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #803.

PFG Investments first reported a position in DGX in Q3 2024 and has held it in 8 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • PFG Investments held 1,842 shares of Quest Diagnostics worth $390K as of Q2 2026.
  • PFG Investments bought 19 Quest Diagnostics shares in Q2 2026, an estimated $3.73K.
  • Quest Diagnostics made up 0.02% of PFG Investments's portfolio in Q2 2026, its #803 holding.
  • PFG Investments first reported a position in Quest Diagnostics in Q3 2024 and has held it in 8 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.